Hematology TimesFDA grants inhibitor fast track designation for AMLMay 19, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesCombo targets AML, BL in the same wayMay 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLNon-Hodgkin Lymphoma
Hematology TimesFDA grants drug orphan designation for AMLMay 15, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesGroup learns how protein promotes AMLMay 15, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAgent preferentially targets FLT3-ITD AMLMay 7, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesTargeting receptors to better treat AMLMay 1, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesSusceptibility to 2nd cancers in WM/LPL survivorsApril 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesCDK inhibitor proves active against AML, ALLApril 26, 2015Leukemia, Myelodysplasia, TransplantationAMLALL
Hematology TimesAML evolution proves unexpectedly complexApril 3, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAML study shows transcription factors are ‘druggable’March 27, 2015Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA approves first biosimilar productMarch 9, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyTransplantationAML
Hematology Times‘Biodegradable’ CAR may aid transplant in AMLMarch 6, 2015Leukemia, Myelodysplasia, TransplantationTransplantationAML
Hematology NewsMinimal residual disease could signify worse outcomes in acute myeloid leukemia treatmentMarch 5, 2015AML
